Other studies have discovered that the expression level of EGR3 mRNA in prostate cancer samples is high, which can be used as a marker for cancer diagnosis and as a prognostic indicator that distinguishes between invasive and noninvasive tumors (Rebecca et al., 2013). Here, EGR3 is linked to cancer.